HUTCHMED (China) Limited (AIM:HCM)
172.00
-10.00 (-5.49%)
Jul 7, 2026, 4:35 PM GMT
HUTCHMED (China) Employees
HUTCHMED (China) had 1,796 employees as of December 31, 2025. The number of employees decreased by 15 or -0.83% compared to the previous year.
Employees
1,796
Change (1Y)
-15
Growth (1Y)
-0.83%
Revenue / Employee
226.92K GBP
Profits / Employee
189.02K GBP
Market Cap
1.48B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 1,796 | -15 | -0.83% |
| Dec 31, 2024 | 1,811 | -177 | -8.90% |
| Dec 31, 2023 | 1,988 | -37 | -1.83% |
| Dec 31, 2022 | 2,025 | 265 | 15.06% |
| Dec 31, 2021 | 1,760 | 480 | 37.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Haleon | 24,535 |
| Hikma Pharmaceuticals | 9,400 |
| Allergy Therapeutics | 584 |
| ECO Animal Health Group | 200 |
| Shield Therapeutics | 61 |
| Venture Life Group | 43 |
| Chill Brands Group | 11 |
| Provexis | 2 |
HUTCHMED (China) News
- 12 hours ago - Hutchmed price target lowered to $17 from $20 at BofA - TheFly
- 5 days ago - HCM Receives Conditional Approval for Orpathys in China - GuruFocus
- 5 days ago - Hutchmed announces China NMPA approval for Orpathys NDA - TheFly
- 5 days ago - HUTCHMED Announces NMPA Approval for ORPATHYS® for the treatment of Gastric Cancer Patients with MET Amplification - GlobeNewsWire
- 7 days ago - HUTCHMED to Announce 2026 Half-Year Financial Results - GlobeNewsWire
- 12 days ago - HUTCHMED Registrational Phase 2 Trial Meets Primary Endpoint For Fanregratinib In Bile Duct Cancer - Nasdaq
- 14 days ago - Syndio Acquires Embrace.ai - Business Wire
- 21 days ago - HUTCHMED (China) Ltd (HCM) Shares Fall 3.5% -- What GF Score of 81 Tells Investors - GuruFocus